FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FGFR4 | Fibroblast growth factor receptor 4 | Cancer-related genes CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FGR | FGR proto-oncogene, Src family tyrosine kinase | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
FLT4 | Fms-related tyrosine kinase 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FRK | Fyn-related Src family tyrosine kinase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
FYN | FYN proto-oncogene, Src family tyrosine kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
GAK | Cyclin G associated kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GRK1 | G protein-coupled receptor kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
GRK4 | G protein-coupled receptor kinase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
GRK5 | G protein-coupled receptor kinase 5 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GRK6 | G protein-coupled receptor kinase 6 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GRK7 | G protein-coupled receptor kinase 7 | Enzymes Predicted intracellular proteins
| | | | | Not detected |
GSG2 | Germ cell associated 2 (haspin) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GSK3A | Glycogen synthase kinase 3 alpha | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GSK3B | Glycogen synthase kinase 3 beta | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
GUCY2D | Guanylate cyclase 2D, membrane (retina-specific) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GUCY2F | Guanylate cyclase 2F, retinal | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Not detected |
HCK | HCK proto-oncogene, Src family tyrosine kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HIPK1 | Homeodomain interacting protein kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK2 | Homeodomain interacting protein kinase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK3 | Homeodomain interacting protein kinase 3 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
HIPK4 | Homeodomain interacting protein kinase 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
HUNK | Hormonally up-regulated Neu-associated kinase | Enzymes Predicted intracellular proteins
| | | | | Mixed |
ICK | Intestinal cell (MAK-like) kinase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
IGF1R | Insulin-like growth factor 1 receptor | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKB | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
IKBKE | Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | Enzymes Predicted intracellular proteins
| | | | | Mixed |
ILK | Integrin-linked kinase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
INSR | Insulin receptor | CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Expressed in all |
INSRR | Insulin receptor-related receptor | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
IRAK2 | Interleukin-1 receptor-associated kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
IRAK3 | Interleukin-1 receptor-associated kinase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRAK4 | Interleukin-1 receptor-associated kinase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ITK | IL2-inducible T-cell kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
JAK1 | Janus kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
JAK2 | Janus kinase 2 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
JAK3 | Janus kinase 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
KALRN | Kalirin, RhoGEF kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KSR1 | Kinase suppressor of ras 1 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KSR2 | Kinase suppressor of ras 2 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LATS1 | Large tumor suppressor kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
LATS2 | Large tumor suppressor kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |